Please select an option below to help us tailor your newsletter to best suit your content interests!
According to the American Cancer Society, more than 14,000 women are expected to be diagnosed with invasive cervical cancer in 2022 with an estimated 4,280 deaths. Cervical cancer was once one of the most common causes of cancer deaths for American women, but early detection from pap smears, HPV vaccines, and new innovative… Read more »
Nancy Childress is a metastatic breast cancer survivor, treated here at West Cancer Center. During the month of June, we asked our West family to share their stories of survivorship to help raise awareness for this disease and to encourage others currently fighting. Nancy was kind enough to share her story with us, written… Read more »
West Cancer Center, Memphis, Tennessee; City of Hope Comprehensive Cancer Center, Duarte, California; Mays Cancer Center, home to UT Health San Antonio MD Anderson, San Antonio, Texas; O’Neal Comprehensive Cancer Center, and University of Alabama at Birmingham, Birmingham, Alabama; comprise the new Advancing Inclusive Research® Site Alliance. This coalition of clinical research sites aims to advance the representation… Read more »
Here at West Cancer Center & Research Institute, we are proud to host our own virtual tumor boards, or Multidisciplinary Conferences, multiple times each week. In these multidisciplinary conferences, we bring together a variety of providers from different disciplines and even institutions to talk about patient cases. It is in these conferences that a group… Read more »
It is with great excitement that our West Cancer Center and Research Institute network adds a new leadership role to our Division of Pharmacy. Camille Hill, PharmD has recently accepted a newly created role of Vice President of Oncology Pharmacy Services, which has become a vital aspect for our network as West continues to grow…. Read more »
Click here to view this full article on OncLive.com. The addition of immune checkpoint inhibitors to chemotherapy has led to durable responses and improved survival without increased toxicity in patients with small cell lung cancer (SCLC), according to David C. Portnoy, MD, FACP, who added that biomarkers of response to this approach and a… Read more »
Oral Abstract Session: Melanoma/Skin Cancers Sunday, June 6, 2021; 8:00 AM–11:00 AM EDT 9501 Final analysis of overall survival (OS) and relapse-free-survival (RFS) in the intergroup S1404 phase III randomized trial comparing either high-dose interferon (HDI) or ipilimumab to pembrolizumab in patients with high-risk resected melanoma. KF Grossmann, M Othus, SP Patel, et al Take-Home Message The… Read more »
West Cancer Center Palliative Care Physician, Dr. W. Clay Jackson, recently co-authored a case report alongside fellow, Jessica Rich, DO, published in Consultant 360. The two detail a patient case regarding pain in a man with opioid-use-disorder who is taking medication assisted therapy. Pain in a Man With Opioid Use Disorder Who Is Taking… Read more »
New technology and treatments for cancer are ever changing. Researching and providing innovative, curative therapies are a top priority at West Cancer Center. Now women managing cervical cancer will have access to MRI-guided brachytherapy treatment as an option – first available in the MidSouth, right here at West. According to the American Cancer Society, cervical… Read more »